Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Accumulated Depreciation (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Accumulated Depreciation for 4 consecutive years, with $45.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Depreciation rose 39.31% to $45.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $45.6 million, a 39.31% increase, with the full-year FY2024 number at $36.1 million, up 57.89% from a year prior.
  • Accumulated Depreciation was $45.6 million for Q3 2025 at Century Therapeutics, up from $39.1 million in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $45.6 million in Q3 2025 to a low of $8.1 million in Q2 2022.
  • A 4-year average of $25.2 million and a median of $24.4 million in 2023 define the central range for Accumulated Depreciation.
  • Peak YoY movement for Accumulated Depreciation: soared 95.01% in 2023, then skyrocketed 39.31% in 2025.
  • Century Therapeutics' Accumulated Depreciation stood at $13.7 million in 2022, then skyrocketed by 67.25% to $22.8 million in 2023, then soared by 57.89% to $36.1 million in 2024, then increased by 26.49% to $45.6 million in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Accumulated Depreciation are $45.6 million (Q3 2025), $39.1 million (Q1 2025), and $36.1 million (Q4 2024).